Summary
AmerisourceBergen Corporation (now Cencora, Inc.) announced on September 8, 2015, the appointment of D. Mark Durcan to its Board of Directors, effective the same day. Mr. Durcan brings extensive executive leadership experience, currently serving as CEO of Micron Technology, Inc., a company where he has a 30-year tenure with a deep background in technology and operations. His appointment is significant as it adds a seasoned leader with a strong track record in a major technology firm to AmerisourceBergen's board.
Key Highlights
- 1D. Mark Durcan appointed to the Board of Directors, effective September 8, 2015.
- 2Mr. Durcan is the CEO and a director of Micron Technology, Inc.
- 3He has 30 years of experience at Micron, holding various leadership roles including President, COO, and CTO.
- 4His prior board experience includes serving as a non-employee director of MWI Veterinary Supply, Inc. before its acquisition by AmerisourceBergen.
- 5Mr. Durcan participated in AmerisourceBergen's acquisition of MWI, tendering shares and having restricted stock vest as part of the transaction.
- 6The filing includes a news release dated September 8, 2015, announcing this director election.
Frequently Asked Questions
D. Mark Durcan is a seasoned executive with 30 years of experience at Micron Technology, Inc., where he currently serves as Chief Executive Officer and a director. His prior roles at Micron include President, Chief Operating Officer, and Chief Technology Officer, indicating a deep understanding of technology and corporate operations.
Mr. Durcan's appointment brings valuable leadership and operational expertise from the technology sector to AmerisourceBergen's Board of Directors. His experience as CEO of a major company like Micron is expected to provide strategic insights and oversight.
Yes, Mr. Durcan previously served as a non-employee director of MWI Veterinary Supply, Inc. (MWI). He participated in AmerisourceBergen's acquisition of MWI, tendering his MWI shares and having restricted stock vest as part of the transaction.
This specific 8-K filing focuses on the director appointment and does not detail compensation arrangements for Mr. Durcan as a director. The filing does disclose his participation in the MWI acquisition, where he received $318,250 for his MWI shares.